Essex Investment Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Essex Investment Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-288,635	Closed	-$4.54M	–	333
2024 Q1	$4.54M	Buy	+288,635	New	+$4.44M	0.9%	30

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Essex Investment Management's DCPH Position: Q2 2024 in Review

Essex Investment Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 288,635 shares — an estimated $4.54M sold.

Essex Investment Management first reported a position in DCPH in Q1 2024 and held it in 1 quarter. The position peaked at $4.54M in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Essex Investment Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Essex Investment Management sold 288,635 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $4.54M.
Essex Investment Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Essex Investment Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $4.54M in Q1 2024.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Essex Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.